Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, Giannasca PJ, Lee CK, Warny M, Monath TP, Kelly CP.

Gastroenterology. 2005 Mar;128(3):764-70.

PMID:
15765411
2.

Active and passive immunization against Clostridium difficile diarrhea and colitis.

Giannasca PJ, Warny M.

Vaccine. 2004 Feb 17;22(7):848-56. Review.

PMID:
15040937
3.

Meeting summary: possibilities for active and passive vaccination against opportunistic infections.

Walker RI, Blanchard T, Braun JM, Cebra JJ, Cross AS, Fattom A, Giannasca PJ, Holder IA, Huebner J, Matthews R, Pier GB, Romani L, von Specht BU, Trautmann M.

Vaccine. 2004 Feb 17;22(7):801-4. No abstract available.

PMID:
15040930
4.

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.

Aboudola S, Kotloff KL, Kyne L, Warny M, Kelly EC, Sougioultzis S, Giannasca PJ, Monath TP, Kelly CP.

Infect Immun. 2003 Mar;71(3):1608-10.

5.

Microparticle targeting to M cells.

Ermak TH, Giannasca PJ.

Adv Drug Deliv Rev. 1998 Dec 1;34(2-3):261-283.

PMID:
10837681
6.
7.

The composition and function of M cell apical membranes: implications for microbial pathogenesis.

Neutra MR, Mantis NJ, Frey A, Giannasca PJ.

Semin Immunol. 1999 Jun;11(3):171-81. Review.

PMID:
10381863
8.

Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.

Giannasca PJ, Zhang ZX, Lei WD, Boden JA, Giel MA, Monath TP, Thomas WD Jr.

Infect Immun. 1999 Feb;67(2):527-38.

9.

Human intestinal M cells display the sialyl Lewis A antigen.

Giannasca PJ, Giannasca KT, Leichtner AM, Neutra MR.

Infect Immun. 1999 Feb;67(2):946-53.

10.

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses.

Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP.

J Exp Med. 1998 Dec 21;188(12):2277-88.

11.

Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.

Giannasca PJ, Boden JA, Monath TP.

Infect Immun. 1997 Oct;65(10):4288-98.

12.
13.

Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor.

Giannasca KT, Giannasca PJ, Neutra MR.

Infect Immun. 1996 Jan;64(1):135-45.

14.

Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines.

Giannasca PJ, Giannasca KT, Falk P, Gordon JI, Neutra MR.

Am J Physiol. 1994 Dec;267(6 Pt 1):G1108-21.

PMID:
7810658
15.

Interactions of microorganisms with intestinal M cells: mucosal invasion and induction of secretory immunity.

Giannasca PJ, Neutra MR.

Infect Agents Dis. 1993 Aug;2(4):242-8. Review. No abstract available.

PMID:
8173803
16.

Transitions between in situ and isolated chromatin.

Giannasca PJ, Horowitz RA, Woodcock CL.

J Cell Sci. 1993 Jun;105 ( Pt 2):551-61.

17.

Ultrastructural preservation of nuclei and chromatin: improvement with low-temperature methods.

Horowitz RA, Giannasca PJ, Woodcock CL.

J Microsc. 1990 Feb;157(Pt 2):205-24.

PMID:
2313684
18.

High-frequency mutations in a plasmid-encoded gas vesicle gene in Halobacterium halobium.

Dassarma S, Halladay JT, Jones JG, Donovan JW, Giannasca PJ, de Marsac NT.

Proc Natl Acad Sci U S A. 1988 Sep;85(18):6861-5.

Supplemental Content

Loading ...
Support Center